Literature DB >> 9000866

Approach to patients with hirsutism.

R Sakiyama1.   

Abstract

Hirsutism is a common medical condition that in most women is due to the polycystic ovary syndrome or is idiopathic. For a few women, hirsutism signals a serious underlying disorder such as an ovarian or adrenal tumor, congenital adrenal hyperplasia, or Cushing's syndrome. A detailed medical history and examination can identify women in whom a serious disease is suspected and for whom laboratory evaluation is warranted. Measurements of serum testosterone, dehydroepiandrosterone, and 17 alpha-hydroxyprogesterone levels, and 24-hour urinary cortisol concentrations are important screening tests. Therapy is directed at suppressing ovarian or adrenal androgen production, inhibiting the conversion of testosterone to dihydrotestosterone, or antagonizing the effects of androgens at the receptor level.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9000866      PMCID: PMC1303883     

Source DB:  PubMed          Journal:  West J Med        ISSN: 0093-0415


  14 in total

1.  Clinical assessment of body hair growth in women.

Authors:  D FERRIMAN; J D GALLWEY
Journal:  J Clin Endocrinol Metab       Date:  1961-11       Impact factor: 5.958

2.  Comparison of a gonadotropin-releasing hormone agonist and a low dose oral contraceptive given alone or together in the treatment of hirsutism.

Authors:  J S Heiner; G A Greendale; A K Kawakami; P S Lapolt; M Fisher; D Young; H L Judd
Journal:  J Clin Endocrinol Metab       Date:  1995-12       Impact factor: 5.958

3.  Screening for sinister causes of hirsutism.

Authors:  T J McKenna
Journal:  N Engl J Med       Date:  1994-10-13       Impact factor: 91.245

Review 4.  Clinical review 56: Nonclassic adrenal hyperplasia: current concepts.

Authors:  R Azziz; D Dewailly; D Owerbach
Journal:  J Clin Endocrinol Metab       Date:  1994-04       Impact factor: 5.958

5.  Use of spironolactone in treatment of hirsutism.

Authors:  D C Cumming
Journal:  Cleve Clin J Med       Date:  1990-05       Impact factor: 2.321

6.  How common are polycystic ovaries in normal women and what is their significance for the fertility of the population?

Authors:  R N Clayton; V Ogden; J Hodgkinson; L Worswick; D A Rodin; S Dyer; T W Meade
Journal:  Clin Endocrinol (Oxf)       Date:  1992-08       Impact factor: 3.478

7.  A prospective randomized trial comparing finasteride to spironolactone in the treatment of hirsute women.

Authors:  I L Wong; R S Morris; L Chang; M A Spahn; F Z Stanczyk; R A Lobo
Journal:  J Clin Endocrinol Metab       Date:  1995-01       Impact factor: 5.958

8.  Leuprolide and estrogen versus oral contraceptive pills for the treatment of hirsutism: a prospective randomized study.

Authors:  R Azziz; T M Ochoa; E L Bradley; H D Potter; L R Boots
Journal:  J Clin Endocrinol Metab       Date:  1995-12       Impact factor: 5.958

Review 9.  Clinical review 73: Medical treatment of androgen-dependent hirsutism.

Authors:  R S Rittmaster
Journal:  J Clin Endocrinol Metab       Date:  1995-09       Impact factor: 5.958

10.  A novel use of spironolactone: treatment of hirsutism.

Authors:  G Shapiro; S Evron
Journal:  J Clin Endocrinol Metab       Date:  1980-09       Impact factor: 5.958

View more
  1 in total

1.  What we see most, we understand least.

Authors:  S K Agarwal; H L Judd
Journal:  West J Med       Date:  1996-12
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.